An observational study in Autoimmune Diseases, Inflammation and Rejection; Transplant, Liver, sponsored by Quell Therapeutics Limited. Recruiting at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by Quell Therapeutics Limited · Observational
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
655 studies on the registry are indexed under Autoimmune Diseases; 275 are open to participants now.
This study's planned enrollment of 10 is below the median of 300 across 208 observational studies indexed under Autoimmune Diseases.
Browse Autoimmune Diseases studies →Quell Therapeutics Limited is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Volunteers willing to provide white blood cells for research.
No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.
Other: White blood cell and blood collection
Mononucleocytes will be collected via apheresis
WBC characterisation to support the development of engineered regulatory T cells.
number, type and function of white blood cells in healthy controls and in patients
Time frame: 5 years
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Quell Therapeutics Limited